Listening
Episodes
One search box across the whole catalog, titles and show notes alike. It earns its keep when you half-remember a case, a device or a name and want the conversation it came up in.
5,508 episodes · 33 shows
Audio unavailableFinal Episode
This week, I have an announcement to make. Find out more athttps://LifeScienceTodayPodcast.comAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about…
- Audio unavailable
Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago
Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyoutFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesSanofi/TakedaUniQure & CSLFog PharmaMerck + Imago About the ShowLife…
- Audio unavailable
Indivior + Opiant, Regeneron + CytomX, Rezo, Provention
A $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvalsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesIndivior + OpiantRegeneron + CytomXRezoPreventionAbout the ShowLife Science Today is…
- Audio unavailable
Intellia, Regeneron, Viatris + Oyster Point
More CRISPR data, oncology wins, and a new player in ophthalmologyFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesIntelliaRegeneronViatris + Oyster PointAbout the ShowLife Science Today is your source for stories, insight…
- Audio unavailable
Sumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, Vaxctye
Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for othersFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesSumitovant + MyovantThermo Fisher + Binding Site GroupAstellas & Tays…
- Audio unavailable
FDA, AbbVie + DJS, Roche + Hookipa, Kyverna
Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future. Find out more athttps://LifeScienceTodayPodcast.comStory References FDAAbbVie + DJSRoche + HookipaKyvernaAbout the ShowLife Science Tod…
- Audio unavailable
DICE, Odyssey, Fred Hutch, Merck (MSD)
One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesDICEOdysseyFred HutchMerck (MSD), Merck Story 2About the Sho…
- Audio unavailable
Nested, Cellarity, Replimune, Estralla
Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPACFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesNested TherapeuticsCellarityReplimuneEstralla BiopharmaAbout the …
- Audio unavailable
Eisai + Biogen, Amylyx, Sanofi + Regeneron
Major Alzheimer’s news, an ALS approval, and expanded therapies for skin conditionsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesEisai + BiogenAmylyxSanofi + RegeneronAbout the ShowLife Science Today is your source for …
- Audio unavailable
Alnylam, Intellia, Third Harmonic, Galvanize
A $900 raise, gene therapy news, a quick IPO, and merge three for $100MFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesAlnylam, Link 2, Link 3Intellia TherapeuticsThird Harmonic BioGalvanize TherapeuticsAbout the ShowLife…
- Audio unavailable
Revance, Velocity + MedPharmics, Arsenal, SpringWorks
A critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesRevanceVelocity + MedPharmicsArsenalSpringWorks Link 1,…
- Audio unavailable
Novo + Forma, Sanofi, Boehringer Ingelheim, Arcturus
A $1.1B acquisition, two FDA approvals, and grants for mRNA vaccines. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesNovo + FormaSanofiBoehringer IngelheimArcturusAbout the ShowLife Science Today is your source for stori…
- Audio unavailable
Alcon + Aerie, Novartis + Sandoz, Labcorp + RWJBH
Ophthalmology acquisitions, following the pharma trends, and a move in healthcare that is not technology related. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesAlcon + AerieNovartis + SandozLabcorp + RWJBHAbout the Show…
- Audio unavailable
Bluebird, Endo & Pharmacies, Genentech + Jemincare, Merck + Orna
Gene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesBluebirdEndo & PharmaciesGenentech + JemincareMerck + OrnaAbout the ShowLife Sci…
- Audio unavailable
Pfizer, Cerevel, Abbott, AstaZeneca + Daiichi Sankyo
Spending that COVID money, brain money, Irish money, and another oncology approval. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesPfizerCerevelAbbottAstaZeneca + Daiichi SankyoAbout the ShowLife Science Today is your so…
- Audio unavailable
Zymergen + Ginkgo, Cassava, Teva
This week, we take a break from stories of raising capital, mergers, and FDA approvals to look at the dark side of our industry. What happens when companies fail, people lie, and good drugs make bad lives? Find out more athttps://LifeScienc…
- Audio unavailable
ZyVersa, Incyte, Revolution, Frontera, CAMP4, ForSight, Auron
There’s a SPAC, expanded FDA approval, more of the common, and two Bs, two AsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesZyVersaIncyteRevolutionFronteraCAMP4ForSightAuronAbout the ShowLife Science Today is your source…
- Audio unavailable
Vertex + ViaCyte, Theravance, Merck + Orion, Pliant, Qiming
Cell therapy acquisition, royalties sold, biobucks-like deal, successful raise, and Chinese Venture Capital Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesVertex + ViaCyteTheravance BiopharmaMerck + OrionPliant Therapeut…
- Audio unavailable
Feed Drop - Interview with Dan Agroskin
FEED DROP - Clinical Research Evolved Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs…
- Audio unavailable
Galapagos + CellPoint + AboundBio, Radius, Ipsen + Epizyme, DEM Bio
Double acquisition, private money, affordable deals, and a surprising $70M launchFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesGalapagos + CellPoint + AboundBioRadiusIpsen + EpizymeDEM Bio About the ShowLife Science Tod…
- Audio unavailable
AbbVie, Third Rock, Scholar Rock, Kyowa Kirin
Crohn’s approval, new VC round, direct offerings, and potential asset sales. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesAbbVieThird RockScholar RockKyowa Kirin About the ShowLife Science Today is your source for stor…
- Audio unavailable
BlueBird, FDA, Resilience, Corvia, Code, Mineralys, Tessa
Gene therapy, minor legislation, a $625M series D, and four companies raise $373M.Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesBlueBirdFDAResilienceCorvia, Code, Mineralys, Tessa About the ShowLife Science Today is you…
- Audio unavailable
GSK + Affinivax, Pfizer – Haleon, Regeneron, Roche + Repare
Pharma buys, pharma splits, pharma trades, and oncology biobucks from pharmaFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesGSK + AffinivaxPfizer – HaleonRegeneronRoche + RepareAbout the ShowLife Science Today is your sou…
- Audio unavailable
Chimex, Emergent, SIGA, Merck & Kelun, Inceptor, Laekna, Kriya
Pox progress, an oncology acquisition, and we look at $360M worth of biotech fundingFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesChimex, Emergent, SIGA Merck & KelunInceptor, Laekna, KriyaAbout the ShowLife Science…